These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 33037651)
1. Fibroblast growth factor-23 as an early marker of CKD-mineral bone disorder in dogs: preliminary investigation. Miyakawa H; Nagatani Y; Ogawa M; Nagakawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N J Small Anim Pract; 2020 Dec; 61(12):744-751. PubMed ID: 33037651 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560 [TBL] [Abstract][Full Text] [Related]
3. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657 [TBL] [Abstract][Full Text] [Related]
4. Serum fibroblast growth factor 23 concentrations in dogs with chronic kidney disease. Dittmer KE; Perera KC; Elder PA Res Vet Sci; 2017 Oct; 114():348-350. PubMed ID: 28667925 [TBL] [Abstract][Full Text] [Related]
5. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease. Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with survival in dogs with chronic kidney disease. Rudinsky AJ; Harjes LM; Byron J; Chew DJ; Toribio RE; Langston C; Parker VJ J Vet Intern Med; 2018 Nov; 32(6):1977-1982. PubMed ID: 30325060 [TBL] [Abstract][Full Text] [Related]
7. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease. Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951 [TBL] [Abstract][Full Text] [Related]
8. Association between serum fibroblast growth factor-23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Vet Intern Med; 2021 Sep; 35(5):2296-2305. PubMed ID: 34418162 [TBL] [Abstract][Full Text] [Related]
9. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease . Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871 [TBL] [Abstract][Full Text] [Related]
11. Update on Mineral and Bone Disorders in Chronic Kidney Disease. Foster JD Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1131-49. PubMed ID: 27436330 [TBL] [Abstract][Full Text] [Related]
12. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease. Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-23 and Alpha-Klotho concentrations in dogs with canine Leishmaniasis. Gultekin G; Ulutas PA Res Vet Sci; 2024 May; 171():105234. PubMed ID: 38547738 [TBL] [Abstract][Full Text] [Related]
14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
15. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy. Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634 [TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor-23 concentrations in young and mature adult cats with chronic kidney disease. Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N J Feline Med Surg; 2022 Aug; 24(8):815-820. PubMed ID: 34431737 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Electrolyte Concentration and Pro-Inflammatory and Oxidative Status in Dogs with Advanced Chronic Kidney Disease under Dietary Treatment. Halfen DP; Caragelasco DS; Nogueira JPS; Jeremias JT; Pedrinelli V; Oba PM; Ruberti B; Pontieri CFF; Kogika MM; Brunetto MA Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31861622 [TBL] [Abstract][Full Text] [Related]
18. A plasma calcium-phosphorus product can be used to predict the lifespan of dogs with chronic kidney disease. Lucero MC; Duque FJ; Gil M; Ruiz P; Macías-García B; Cristóbal JI; Zaragoza C; Barrera R Can Vet J; 2019 Dec; 60(12):1319-1325. PubMed ID: 31814639 [TBL] [Abstract][Full Text] [Related]
19. Calcium and phosphorus homeostasis in dogs with spontaneous chronic kidney disease at different stages of severity. Cortadellas O; Fernández del Palacio MJ; Talavera J; Bayón A J Vet Intern Med; 2010; 24(1):73-9. PubMed ID: 19925576 [TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J; Liu S; Quarles LD Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]